AN2 Therapeutics (ANTX)
(Delayed Data from NSDQ)
$1.02 USD
-0.01 (-0.97%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $1.02 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for AN2 Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -64.73 | -40.96 | -21.54 | -13.60 | NA |
Depreciation/Amortization & Depletion | -2.86 | -0.69 | 0.05 | 0.00 | NA |
Net Change from Assets/Liabilities | 5.17 | 3.72 | 0.03 | 1.22 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 9.13 | 4.47 | 0.97 | 7.02 | NA |
Net Cash From Operating Activities | -53.29 | -33.46 | -20.48 | -5.36 | NA |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | -43.28 | -21.77 | -50.02 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | -43.28 | -21.77 | -50.02 | 0.00 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 84.99 | 70.36 | 79.75 | 3.84 | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | 0.00 | -1.21 | 0.00 | NA |
Net Cash from Financing Activities | 84.99 | 70.36 | 78.54 | 3.84 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -11.57 | 15.12 | 8.03 | -1.53 | NA |
Cash at Beginning of Period | 27.22 | 12.10 | 4.07 | 5.60 | NA |
Cash at End of Period | 15.65 | 27.22 | 12.10 | 4.07 | NA |
Diluted Net EPS | -2.74 | -2.79 | -10.64 | NA | NA |
Fiscal Year End for AN2 Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -31.05 | -16.62 | -64.73 | -47.83 | -31.13 |
Depreciation/Amortization & Depletion | -1.98 | -1.09 | -2.86 | -1.55 | -0.90 |
Net Change from Assets/Liabilities | -3.49 | -1.92 | 5.17 | 5.96 | 3.55 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 4.55 | 2.04 | 9.13 | 7.21 | 4.05 |
Net Cash From Operating Activities | -31.98 | -17.59 | -53.29 | -36.22 | -24.42 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 42.75 | 26.29 | -43.28 | -43.70 | 18.76 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 42.75 | 26.29 | -43.28 | -43.70 | 18.76 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.35 | 0.35 | 84.99 | 85.32 | 19.25 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.35 | 0.35 | 84.99 | 85.32 | 19.25 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 11.12 | 9.05 | -11.57 | 5.40 | 13.59 |
Cash at Beginning of Period | 15.65 | 15.65 | 27.22 | 27.22 | 27.22 |
Cash at End of Period | 26.77 | 24.69 | 15.65 | 32.62 | 40.81 |
Diluted Net EPS | -0.48 | -0.56 | -0.49 | -0.65 | -0.81 |